“Abiraterone Acetate in Patients with Advanced Castrate Resistant Prostate Cancer: Initial Real Life Experience in 2 Cancer Units” (2016) Journal of Analytical Oncology, 5(1), pp.  42–46. doi:10.6000/1927-7229.2016.05.01.6.